Back
Summit Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
SMMT
Summit Therapeutics, Inc.
Last Price:
$16.20
Seasonality Move:
15.49%
7 Day Trial
ALL ACCESS PASS
$
7
Summit Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Summit Therapeutics, Inc. has on average historically risen by 67% based on the past 11 years of stock performance.
-
Summit Therapeutics, Inc. has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
-
Is Summit Therapeutics, Inc. Stock Undervalued?The current Summit Therapeutics, Inc. [SMMT] share price is $16.59. The Score for SMMT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Summit Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Summit Therapeutics, Inc. has on average historically risen by 67% based on the past 11 years of stock performance.
Summit Therapeutics, Inc. Stock Rating
Sell
34
Summit Therapeutics, Inc. (SMMT)
is a Sell
Is Summit Therapeutics, Inc. overpriced?
-
Summit Therapeutics, Inc. has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Summit Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com
52-Week Data
52-Week High:
36.91
52-Week Low:
13.83
Prediction Charts
Market Cap:
12.4B
Price in USD:
16.59
Volume:
2.4M
Beta:
-0.25
Technical Analysis
SMA50:
16.54
SMA100:
17.74
SMA200:
20.56
52-Wk Change:
-10.28%
Stock Predictions
-
Is Summit Therapeutics, Inc. stock public?Yes, Summit Therapeutics, Inc. is a publicly traded company.
-
What is the Summit Therapeutics, Inc. stock quote today?The Summit Therapeutics, Inc. stock price is 16.59 USD today.
-
How to buy Summit Therapeutics, Inc. stock online?You can buy Summit Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 15.00 | 14.97 | 15.08 | 14.66 |
| Feb-10 | 15.22 | 15.25 | 15.77 | 15.03 |
| Feb-11 | 15.27 | 15.25 | 15.51 | 14.64 |
| Feb-12 | 15.31 | 14.63 | 15.39 | 14.58 |
| Feb-13 | 14.74 | 14.96 | 15.57 | 14.67 |
| Feb-17 | 14.85 | 15.68 | 15.99 | 14.85 |
| Feb-18 | 15.57 | 15.88 | 16.16 | 15.49 |
| Feb-19 | 15.67 | 15.87 | 15.89 | 15.39 |
| Feb-20 | 15.68 | 15.94 | 16.21 | 15.66 |
| Feb-23 | 15.75 | 16.09 | 16.27 | 15.72 |
| Feb-24 | 15.78 | 16.12 | 16.80 | 15.50 |
| Feb-25 | 16.17 | 15.68 | 16.51 | 15.64 |
| Feb-26 | 15.72 | 15.80 | 15.82 | 15.36 |
| Feb-27 | 15.61 | 16.59 | 16.61 | 15.56 |
Summit Therapeutics, Inc. Earnings
Summit Therapeutics, Inc. Earnings Report: Per Share Summit Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Summit Therapeutics, Inc. Forecast Revenue Growth
Summit Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.10 per share, and an increase next year of $0.01 per share.
* Summit Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.